Generics 39

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Flavoxate manufacturers

39 products found

Filters

39 products found

flavoxate

Tablets, film coated 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18161
This company operates in the pharmaceutical industry and has been in the market for a few decades, focusing on providing affordable healthcare solutions to the public. They are dedicated to offering quality products and services that exceed customer expectations. The company prioritizes research and development, aiming to become an integrated pharmaceutical industry with a strong focus on biotechnology and original drug research. Their commitment to social responsibility is reflected in their efforts to make quality medication accessible to all. The company manufactures a range of products, including prescription and over-the-counter medications, and has obtained GMP certifications for its production lines. Their main areas of focus include oncology and cardiology, with a diverse portfolio encompassing various dosage forms, including solids, injectables, and liquids. They hold patents for certain formulations and are active in several key regions including North America and the EU.

Manufacturer usually replies in 2 days

flavoxate

Tablets tbt

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
Manufacturer #1403
This company, headquartered in the Middle East, has been operating for over two decades, focusing on both human and veterinary pharmaceuticals. They produce a range of products including prescription and over-the-counter medications, and leverage a team of skilled pharmacists, veterinarians, marketing and sales experts to deliver quality products. The company has a strong commitment to providing affordable and safe healthcare solutions. Their primary therapy areas are not clearly stated, but their commitment to quality products suggests a focus on general health and wellness, potentially including areas like pain management and infection control. They manufacture a variety of dosage forms including solids, injectables, and liquids. The company operates under EU and USA GMP regulations, ensuring adherence to international standards.

Manufacturer usually replies in 8 days

flavoxate

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21340
The company is a leading conglomerate with a diverse range of business operations across multiple industries. The website is structured to provide detailed financial information through sections like “Annual Report,” “Quarterly Report,” and “Price Sensitive Information,” which include links to various reports from recent years and updates on financial performance, such as notices about bond issuances. The company operates in several key sectors, including textiles, pharmaceuticals, personal protective equipment (PPE), ceramics, information and communication technology (ICT), real estate and trading, media, financial services, energy, and travel and tourism. As the largest entity within its group, the company plays a significant role in driving economic activities and growth across these industries, reflecting its strong market presence and commitment to diversified business interests.

Manufacturer usually replies in 8 days

Want to see all 39 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Flavoxate:

Flavoxate is an anticholinergic with antimuscarinic effects, it is used as a medication for its muscle relaxant properties. Where it is used to treat urinary bladder spasms and other similar ailments. It is produced by manufacturers under the trade names of Urispas (Paladin, India), Genurin (Recordati, Italy), Uritac (El Saad company, Syria), Bladderon (Nippon Shinyaku, Japan), Bladuril (Chile), and Utispas (Apex Pharma, Nepal). Flavoxate was originally approved for use in the United States in 1970 and since has become popular in the global medical marketplace. Where, due to its emergence into the generic drugs space, it has seen frequent production and commercialization by flavoxate manufacturers and flavoxate suppliers. It is now often found on the pharmaceutical products for sale list of global distributors, where it is available for wholesale order at a variety of cost and price points.

Method of action of flavoxate:

Flavoxate belongs to a group of drugs which function as spasmolytic flavone derivatives and it specifically functions by relaxing the smooth muscles in the urinary tract. Although the exact mechanism of action remains elusive, it is known that flavoxate functions as a direct antagonist at muscarinic acetylcholine receptors in cholinergic innervated organs. This anticholinergic and parasympatholytic effect reduces the tonus of smooth muscle in the bladder, causing a reduction in the need to urinate and an increase in retention and subsequent volume per urination.

Form and dosage of flavoxate:

The final form and packaging are dependent on the manufacturers and suppliers, as well as the specific distributors and order. However, flavoxate typically comes in forms including tablets, film-coated tablets, and capsules. The recommended dose for adult patients for all clinical indications is 200 mg 3 times a day, taken by mouth. Special caution and subsequent dose adjustment should be taken with the elderly and young. Side effects are predominantly non-serious and include constipation, dizziness, and drowsiness. For a complete list of possible complications and additional information please refer to the manufacturers’ literature or an accredited healthcare provider.

Flavoxate on Pipelinepharma:

Currently, at the time of writing, we have found 2 verified flavoxate manufacturers and flavoxate suppliers from our online global list of B2B sellers. These manufacturers, suppliers, and distributors are located in countries including Egypt and Lebanon. Each company and their pharmaceutical products list displayed on our online B2B platform has been verified by the Pipelinepharma team. This ensures seller reputability and reduces sourcing mileage, allowing for a fluent business experience for all involved parties.

Price of flavoxate and how to buy:

A cursory search online reveals an approximate wholesale cost for flavoxate to be £11.67 for 200 mg x 90 tablets. These values are indicated for the NHS in the UK. As such they are only intended to serve as a generalization of the current market conditions. Although the prices on the B2B wholesale Pipelinepharma marketplace remain confidential between both B2B parties, the seller may choose to list the desired price to facilitate the online transaction. If so, an ‘Accept’ and ‘Negotiate’ button will be displayed through the online interface, with a ‘Get offer’ button being shown in the absence. This makes it easy to find new qualified sellers for your pharmaceutical business. Simply use our online search tool, filter by your wanted criteria, and finally select the desired listing.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible